SKSatomi Kobayashi

Satomi Kobayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Satomi Kobayashi has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association Between Wrist-Worn Device-Estimated Sleep Efficiency and Hand Grip Strength in Older Outpatients With Cardiometabolic Diseases: Cross-Sectional Study

    by Yoshiaki Tamura, Rui Gong, Yuji Murao, Fumino Kobayashi, Satomi Kobayashi, Remi Kodera, Kazuhito Oba, Maki Shirobe, Kenji Toyoshima, Kanae Kubo, et al.

    Background: Older outpatients with chronic diseases are susceptible to muscle weakness and functional disabilities. Recently, various wearable devices have been developed to generate health lifelogs in daily life; however, data from patients with chronic diseases remain scarce. Previous studies have shown that subjective sleep efficiency assessed by self-questionnaires is associated with grip strength, but whether objective sleep efficiency detected by wearable devices is associated with physical function and body composition remains unclear. Objective: The aim of this study is to clarify the association between sleep duration, sleep efficiency estimated by wearable watch, grip strength, frailty, and sarcopenia in outpatients with predominantly cardiometabolic diseases and the influence of diabetes as part of the Smart Watch Innovation for Geriatrics and Gerontology (SWING-Japan) project. Methods: In this cross-sectional study, the wrist-worn device Silmee 22 was used in an outpatient clinic of an acute care facility for 7‐90 nights for the analyses, and individual average sleep duration and efficiency (wearable-estimated sleep efficiency: total sleep duration/time spent in bed) were calculated. Low grip strength was defined as P =.006, 245 vs 276 min, P =.04). Wearable-estimated sleep efficiency was not associated with frailty, low muscle mass, or slow walking speed. After adjusting for the above variables, low wearable-estimated sleep efficiency, but not low sleep duration, was associated with a risk of lower grip strength (odds ratio 1.04, 95% CI 1.01‐1.08; P =.02) by 1 percentage point decrease in wearable-estimated sleep efficiency. This association was observed in patients with diabetes (odds ratio 1.05, 95% CI 1.002‐1.093; P =.04). However, no significant interaction was observed. Conclusions: In older patients with cardiometabolic diseases, objective low wearable-estimated sleep efficiency evaluated with wrist-worn wearable devices was associated with low muscle strength. No evidence was found to suggest that the strength of this association differed according to diabetes status. Longitudinal studies are needed to clarify the long-term association between low wearable-estimated sleep efficiency and muscle strength in this population.

  • Control of naive and effector CD4 T cell receptor repertoires by rheumatoid-arthritis-risk HLA alleles

    by Yasuo Nagafuchi, Mineto Ota, Hiroaki Hatano, Mariko Inoue, Satomi Kobayashi, Mai Okubo, Yusuke Sugimori, Masahiro Nakano, Saeko Yamada, Ryochi Yoshida, et al.


  • Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis

    by Satomi Kobayashi, Yasuo Nagafuchi, Mai Okubo, Yusuke Sugimori, Hiroaki Hatano, Saeko Yamada, Masahiro Nakano, Ryochi Yoshida, Yusuke Takeshima, Mineto Ota, et al.

    Objectives: We evaluated flow-cytometric and transcriptome features of peripheral blood immune cells from early-phase (disease duration <5 years) SSc in comparison with late-phase SSc. Methods: Fifty Japanese patients with SSc (12 early SSc cases and 38 late SSc cases) and 50 age- and sex-matched healthy controls were enrolled. A comparison of flow-cytometric subset proportions and RNA-sequencing of 24 peripheral blood immune cell subsets was performed. We evaluated differentially expressed genes (DEGs), characterized the co-expressed gene modules, and estimated the composition of subpopulations by deconvolution based on single-cell RNA-sequencing data. As a disease control, idiopathic inflammatory myositis (IIM) patients were also evaluated. Results: Analysing the data from early and late SSc, fraction II effector regulatory T cell (Fr. II eTreg) genes showed a remarkable differential gene expression, enriched for genes related to oxidative phosphorylation. Although the flow-cytometric proportion of Fr. II eTregs was not changed in early SSc, deconvolution indicated expansion of the activated subpopulation. Co-expressed gene modules of Fr. II eTregs demonstrated enrichment of the DEGs of early SSc and correlation with the proportion of the activated subpopulation. These results suggested that DEGs in Fr. II eTregs from patients with early SSc were closely associated with the increased proportion of the activated subpopulation. Similar dysregulation of Fr. II eTregs was also observed in data from patients with early IIM. Conclusions: RNA-seq of immune cells indicated the dysregulation of Fr. II eTregs in early SSc with increased proportion of the activated subpopulation.


  • Open Access

    Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy

    by Norio Hanata, Yasuo Nagafuchi, Yusuke Sugimori, Satomi Kobayashi, Yumi Tsuchida, Yukiko Iwasaki, Hirofumi Shoda, Keishi Fujio

    Background. The epidermal growth factors amphiregulin (AREG) and heparin-binding epidermal growth factor (HB-EGF) are implicated in the pathogenesis of several autoimmune diseases, but their clinical and pathological roles in idiopathic inflammatory myopathy (IIM) are unclear. Methods. Serum AREG and HB-EGF levels were measured by ELISA in patients with IIM (n = 37), systemic sclerosis (n = 17), and rheumatoid arthritis (n = 10), and for seven age- and sex-matched healthy controls (HCs). Associations between serum AREG or HB-EGF levels and the clinical parameters were analyzed. Results. Serum AREG levels in IIM patients were significantly elevated compared to those in HCs (median, 20.7 and 10.7 pg/mL, respectively; p = 0.025). In particular, serum AREG levels in IIM patients with interstitial lung disease (ILD) were higher than those of HCs (22.4 pg/mL, p = 0.027). The disease duration in patients with elevated serum AREG levels was significantly shorter compared to those who had normal serum AREG levels (7 and 21 months, respectively; p = 0.0012). Serum HB-EGF levels were significantly increased in IIM patients with elevated CK levels (136.2 pg/mL; p = 0.020) and patients with anti-Mi-2 antibody (183.7 pg/mL; p = 0.045) compared to those in HCs (74.9 pg/mL). Conclusion. These results suggested that AREG could be a promising biomarker associated with early-phase IIM-related ILD, and that HB-EGF expression was associated with muscle injury and regeneration in IIM.


  • Top Cited Papers

    Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases

    by Mineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, Kazuyoshi Ishigaki, Chikashi Terao, Yusuke Takeshima, Haruyuki Yanaoka, Satomi Kobayashi, Mai Okubo, Harumi Shirai, et al.


  • Performance of hands and feet radiographs in differentiation of psoriatic arthritis from rheumatoid arthritis

    by Naomi Ichikawa, Atsuo Taniguchi, Satomi Kobayashi, Hisashi Yamanaka

    Aim: The purpose of this study was to determine useful radiographic findings for differentiating psoriatic arthritis (PsA) from rheumatoid factor (RF)‐positive or ‐negative rheumatoid arthritis (RA) in Japanese patients.Methods: We accrued 85 patients with PsA. Controls included 135 patients with RA (85 RF‐positive, 50 RF‐negative) matched for gender and disease duration with PsA patients. Radiographs of hands and feet were obtained, and distal interphalangeal (DIP) erosive disease, joint osteolysis, tuft osteolysis, juxta‐articular bony proliferation (JBP), periosteal new bone formation and bony ankylosis, which were identified using the definitions developed by an earlier study, were compared between the PsA and RA groups.Results: For radiographic features of hands, the frequencies of JBP, periosteal new bone, and diffuse soft tissue swelling of the fingers were significantly higher in PsA patients than in RF‐positive RA patients. However, only the frequency of JBP significantly differed between PsA and RF‐negative RA patients. In feet, the frequencies of DIP erosive disease, tuft osteolysis, JBP, and diffuse soft tissue swelling of the toes were significantly higher in PsA patients than in RF‐positive RA patients. However, only the frequency of JBP significantly differed between PsA and RF‐negative RA patients.Conclusion: JBP was the most important radiographic feature for discriminating PsA from both RF‐positive and ‐negative RA, confirming the study by the CASPAR group that showed that JBP is the only radiologic feature that can discriminate PsA from other inflammatory arthritides. This study showed the utility of plain radiographs for diagnosis of PsA.


  • Tonsil-Related Skin Diseases and Possible Involvement of T Cell Co-Stimulation in Chronic Focal Infection

    by Satomi Kobayashi

    Some inflammatory skin diseases are known to be related to tonsil focal infection at their onset. Administration of antibiotics is adequate treatment in most acute or subacute cases. However, chronic focal infections in the tonsils could cause chronic skin diseases like pustulosis palmaris et plantaris (PPP), and it is our frequent experience that tonsillectomy leads to a dramatic and persistent improvement of PPP skin lesions. The expression of inducible co-stimulator (ICOS), a co-stimulatory receptor on activated T cells, was significantly higher in tonsil tissues from PPP patients than in tonsil tissues from non-PPP patients. Moreover, ICOS expression in tonsil tissues from 3 patients with psoriasis vulgaris that was strongly suspected to be related to tonsil focal infection was also high, suggesting that the activation of T cells via ICOS costimulation in focal infections likely triggers inflammation associated with tonsil-related skin diseases. PPP is notable today for paradoxically induced skin lesions in patients treated with TNF-α antagonists for rheumatoid arthritis, Crohn's disease, psoriasis and psoriatic arthritis. It is important to clarify the immunological milieu in PPP not only for the treatment approach but also for understanding these unexpected reactions.


  • Treatment of Behçet's disease with diamino-diphenyl sulphone (DDS)

    by H. Nishimura, Y. Horiguchi, I. Matsumoto, S. Kobayashi, K. Fujii, T. Tanaka, F. Furukawa, S. Imamura

    Diamino-diphenyl sulphone (DDS) was given to three patients with Behçet's disease. One patient was treated with DDS for orogenital ulcers, cutaneous symptoms and arthralgia. The other two were being treated with oral corticosteroid, and DDS was added. In all cases, DDS therapy improved cutaneous manifestations of Behçet's disease, and enabled a lowering of the dosage of oral corticosteroids in one case.